Basic HTML Version
8
Citi Depositary Receipts
DR IPOs
1
Issuer
Country
Industry
2
USD Value (in Millions)
Videocon d2h Ltd
India
Media
$362
Galapagos NV*
Belgium
Pharmaceuticals
$242
Cellectis S.A.*
France
Biotechnology
$228
Adaptimmune Therapeutics plc*
UK
Biotechnology
$191
Edita Food Industries S.A.E.
Egypt
Food
$160
Ascendis Pharma A/S
Denmark
Pharmaceuticals
$124
Baozun Inc.
China
Internet
$110
Nabriva Therapeutics AG
Austria
Biotechnology
$106
TWi Pharmaceuticals, Inc.*
Taiwan
Pharmaceuticals
$87
Advanced Accelerator Applications S.A.
France
Healthcare-Products
$86
Celyad S.A.*
Belgium
Biotechnology
$80
Yirendai Ltd
China
Internet
$75
Mesoblast Ltd.
Australia
Biotechnology
$68
Biotie Therapies
Finland
Pharmaceuticals
$64
Jupai Holdings Ltd.
China
Investment Companies
$59
Wowo Limited*
China
Internet
$42
Summit Therapeutics plc
UK
Pharmaceuticals
$39
Hailiang Education Group Inc.
China
Commercial Services
$20
Benitec Biopharma Limited
Australia
Biotechnology
$14
Kitov Pharmaceuticals Holdings Ltd.
Israel
Pharmaceuticals
$13
Oasmia Pharmaceutical AB
Sweden
Pharmaceuticals
$10
BiondVax Pharmaceuticals Ltd
Israel
Pharmaceuticals
$10
Grand Total
$2,193
Source: Bloomberg and Depositary Data Interchange
1
Defined as capital raising at the time of listing of a new DR security
2
Industry as defined by Bloomberg
DR Capital Raisings
(continued)
*Signifies Citi DR program capital raising
IPO Deals in
bold italics
signify a JOBS Act Deal